Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Squamous Cell Carcinoma 23Carcinoma, Hepatocellular 23Stomach Neoplasms 14Colorectal Neoplasms 13Liver Neoplasms 7Esophageal Neoplasms 6Rectal Neoplasms 5Pancreatic Neoplasms 4Cholangiocarcinoma 4Locally Advanced Rectal Cancer 3Biliary Tract Neoplasms 3Advanced Pancreatic Cancer 3Turcot syndrome 2Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Microsatellite Stable Metastatic Colorectal Cancer 2Klatskin Tumor 2Gallbladder Neoplasms 2Early Low Rectal Cancer 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma of the Stomach 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Carcinoma of Esophagus 1Sarcoma 1Radiotherapy 1Pathologic Complete Response 1Pancreatic Cancer Metastatic 1

Interventions

toripalimab 2Oxaliplatin 2tesetaxel 1indusatumab 1Trastuzumab 1S 1 (combination) 1Nivolumab 1Leucovorin 1Ipilimumab 1GC1118 1Fluorouracil 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Adenocarcinoma of the Stomach × toripalimab × Gastrointestinal × Clear all
NCT05715931 2024-09-19

Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

First Affiliated Hospital of Zhejiang University

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Adenocarcinoma of the Stomach

NCT05970627 2023-08-01

Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

First Affiliated Hospital of Zhejiang University

Phase 2 Not yet recruiting
30 enrolled
Gastrointestinal

Adenocarcinoma of the Stomach

Data powered by HemOnc (CC BY 4.0) Colophon âš¡